# Iambic Therapeutics Plans Nasdaq IPO Above $800 Million Valuation

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/28101
Published: 2026-10-08T13:25:04.000Z
Updated: 2026-10-08T13:25:04.000Z
Section: Business

> The Nvidia- and AbbVie-backed life sciences company plans to list under the ticker IAM and leverages artificial intelligence.

Iambic Therapeutics plans to list on Nasdaq under the ticker IAM at a valuation exceeding $800 million.

The Nvidia- and AbbVie-backed life sciences company uses artificial intelligence and described the proposed listing Thursday.